HIGHLIGHTS
- who: Etienne de Montmollin and colleagues from the Université Paris Cité, INSERM, UMR, IAME, Paris, France have published the research work: Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS, in the Journal: Antibiotics 2022, 1166 of 12/09/2021
- what: Acute hypoxemic respiratory failure is the main reason for intensive care unit (ICU) admission, and critically ill COVID-19 patients show mortality rates up to 40% . The authors aimed to evaluate MR-proADM as a prognostic biomarker in critically ill patients with severe SARS-CoV-2 pneumonia, and as a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.